Rett syndrome, MECP2 and therapeutic strategies
Rudolf Jaenisch · Whitehead Institute for Biomedical Research and Department of Biology, MIT, Cambridge, USA
MECP2
10 items · last seminar 11 Dec 2024
10 results
Newest first
Seminar1
2024
ePosters9
FENS 2024
Brain-wide circuitry underlying altered auditory habituation in zebrafish models of autism
Maya Wilde, Anahita Ghanbari, Tessa Mancienne et al.
The intrinsic properties of somatostatin interneurons in a Mecp2-deficient mouse model of Rett syndrome
Abinayah John, Asma Soltani, Ole Paulsen
Investigation of protein replacement therapy for Rett Syndrome using directly reprogrammed neurons
Hannes Steinkellner, Anna M. Huber, Victoria Sarne et al.
The use of a shortened MeCP2 protein construct in Rett syndrome protein replacement therapy
Alexander Beribisky, Hannes Steinkellner, Claudia Sulek et al.
Testing the therapeutic effects of autophagy enhancement in a Rett syndrome mouse model
Tommaso Seri, Gaia Tartaglione, Francesca Nuzzolillo et al.
In vitro analysis of mitochondrial abnormalities and oxinflammatory mechanisms involved in Rett Syndrome
Gabriele Baj, Matteo Muccini, Gaia Tartaglione et al.
In vitro Rett syndrome model based on MeCP2 knockdown in iPSC-derived neurons
Rie Yamoto, Mika Nakao, Toru Hazama, Toshihiko Hosoya
In vivo xenotransplantation of patient iPSC-derived neurons in MECP2 neurodevelopmental disorders
Nona Merckx, Leïla Boubakar, Ryohei Iwata et al.
COSYNE 2022
Parvalbumin-positive interneuron regulation of maternal pup retrieval behavior
Alexa Pagliaro, Julia Wang, Deborah Rupert, Stephen D Shea